178 related articles for article (PubMed ID: 28247750)
41. Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity.
Kumar P; Wasim L; Chopra M; Chhikara A
AAPS PharmSciTech; 2018 Feb; 19(2):634-647. PubMed ID: 28948528
[TBL] [Abstract][Full Text] [Related]
42. Positively Charged Combinatory Drug Delivery Systems against Multi-Drug-Resistant Breast Cancer: Beyond the Drug Combination.
Yan X; Yu Q; Guo L; Guo W; Guan S; Tang H; Lin S; Gan Z
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6804-6815. PubMed ID: 28185449
[TBL] [Abstract][Full Text] [Related]
43. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
44. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
45. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
46. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
47. Platinum-Coordinated Dual-Responsive Nanogels for Universal Drug Delivery and Combination Cancer Therapy.
Duan QY; Zhu YX; Jia HR; Guo Y; Zhang X; Gu R; Li C; Wu FG
Small; 2022 Nov; 18(46):e2203260. PubMed ID: 36333101
[TBL] [Abstract][Full Text] [Related]
48. Cell-targeted, dual reduction- and pH-responsive saccharide/lipoic acid-modified poly(L-lysine) and poly(acrylic acid) polyionic complex nanogels for drug delivery.
How SC; Chen YF; Hsieh PL; Wang SS; Jan JS
Colloids Surf B Biointerfaces; 2017 May; 153():244-252. PubMed ID: 28267669
[TBL] [Abstract][Full Text] [Related]
49. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
[TBL] [Abstract][Full Text] [Related]
50. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
[TBL] [Abstract][Full Text] [Related]
51. Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
Gong MQ; Wu C; He XY; Zong JY; Wu JL; Zhuo RX; Cheng SX
Pharm Res; 2017 Jan; 34(1):148-160. PubMed ID: 27738951
[TBL] [Abstract][Full Text] [Related]
52. Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy.
Di H; Wu H; Gao Y; Li W; Zou D; Dong C
Drug Dev Ind Pharm; 2016 Dec; 42(12):2038-2043. PubMed ID: 27184819
[TBL] [Abstract][Full Text] [Related]
53. Cisplatin-crosslinked glutathione-sensitive micelles loaded with doxorubicin for combination and targeted therapy of tumors.
Zhang X; Li L; Li C; Zheng H; Song H; Xiong F; Qiu T; Yang J
Carbohydr Polym; 2017 Jan; 155():407-415. PubMed ID: 27702529
[TBL] [Abstract][Full Text] [Related]
54. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
55. Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin.
Kumar P; Behl G; Sikka M; Chhikara A; Chopra M
J Biomater Sci Polym Ed; 2016 Oct; 27(14):1413-33. PubMed ID: 27383582
[TBL] [Abstract][Full Text] [Related]
56. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
Shieh MJ; Hsu CY; Huang LY; Chen HY; Huang FH; Lai PS
J Control Release; 2011 Jun; 152(3):418-25. PubMed ID: 21435362
[TBL] [Abstract][Full Text] [Related]
57. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
58. Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer.
Feng C; Rui M; Shen H; Xin Y; Zhang J; Li J; Yue L; Lai W; Xu X
Int J Pharm; 2017 Aug; 528(1-2):322-333. PubMed ID: 28606508
[TBL] [Abstract][Full Text] [Related]
59. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
Gao W; Ye G; Duan X; Yang X; Yang VC
Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
[TBL] [Abstract][Full Text] [Related]
60. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
